PCORI Board Approves $254 Million to Fund 28 New Research Studies
At its July 2021 meeting, the Board approved significant funding for studies to address urgent health problems, including $33 million to strengthen pre- and post-natal care for Black women and $58 million to assess strategies to prevent youth suicide. Find out more
Two Newly Funded Studies Target COVID-19 Vaccine Hesitancy
PCORI has approved nearly $11 million in new funding for two new studies comparing ways to reduce COVID-19 vaccine hesitancy among workers in skilled nursing facilities and other long-term care settings. The studies are based in New Hampshire and Washington state. Find out more
PCORI Launches Public Comment Period on New National Priorities
Public comment on five proposed National Priorities for Health — which will serve as a framework to guide PCORI’s funding decisions and related initiatives, and were developed with input from patients and healthcare decision makers — is open through Aug. 27. Learn more
Building Effective Multi-Stakeholder Research Teams
To support diverse research teams, PCORI is pleased to announce the release of a new, free website that offers evidence-based information and more than 50 resources in two key areas: engaging stakeholders and working as a team. Learn more
Our Commitment to Diversity, Equity, and Inclusion
In her latest Leadership Perspective, Executive Director Nakela L. Cook, MD, MPH, discusses her commitment to enhancing our work against racism, bias, and discrimination and promoting diversity, equity, and inclusion in all that we do. Read more
Biweekly COVID-19 Scan (July 8-21, 2021)
Our latest brief—in a series on the evolving landscape of potentially impactful applications for COVID-19—covers calls to reinstate mask mandates and a potential drug for patients at high risk of disease progression to acute respiratory distress syndrome. Read more
Results of ADAPTABLE Study on Aspirin Dosing Presented at ACC.21, Published in NEJM
In the largest aspirin dosing trial conducted in routine care and clinical settings, people with heart disease who took aspirin to lower their risk of a heart attack or stroke experienced similar benefits, whether they took high- or low-dose aspirin. Learn more
NIH-funded Study of Repurposed Drugs for COVID-19 Taps PCORnet
The NIH's ACTIV-6 clinical trial platform will use PCORnet®, the National Patient-Centered Clinical Research Network, to help accelerate the study of some prescription and over-the-counter medications as treatments for COVID-19 in non-hospitalized patients. Read more